These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35699041)

  • 1. Developmental artificial neural network model to evaluate the preoperative safe limit of future liver remnant volume for HCC combined with clinically significant portal hypertension.
    Lu HZ; Mai RY; Wang XB; Chen J; Bai T; Ma L; Xiang BD; Cheng SQ; Guo WX; Li LQ; Ye JZ
    Future Oncol; 2022 Jul; 18(21):2683-2694. PubMed ID: 35699041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension.
    Ye JZ; Lu HZ; Zeng C; Lei G; Wang XB; Chen J; Bai T; Wu FX; Mai RY; Guo WX; Li LQ
    BMC Cancer; 2024 Jun; 24(1):764. PubMed ID: 38918786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
    Long H; Peng C; Ding H; Zheng Y; Zhou J; Chen W; Zhong X; Shi Y; Duan Y; Xie X; Kuang M; Xie X; Lin M
    Eur Radiol; 2023 Nov; 33(11):7665-7674. PubMed ID: 37314474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma.
    Mai RY; Lu HZ; Bai T; Liang R; Lin Y; Ma L; Xiang BD; Wu GB; Li LQ; Ye JZ
    Surgery; 2020 Oct; 168(4):643-652. PubMed ID: 32792098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study.
    Ye JZ; Mai RY; Guo WX; Wang YY; Ma L; Xiang BD; Cheng SQ; Li LQ
    BMC Cancer; 2020 Oct; 20(1):1036. PubMed ID: 33115425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection.
    Hsieh CB; Yu CY; Tzao C; Chu HC; Chen TW; Hsieh HF; Liu YC; Yu JC
    Eur J Surg Oncol; 2006 Feb; 32(1):72-6. PubMed ID: 16246517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Choi SB; Kim HJ; Song TJ; Ahn HS; Choi SY
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):639-47. PubMed ID: 24867654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: a meta-analysis.
    Tang YH; Zhu WJ; Wen TF
    Asian Pac J Cancer Prev; 2014; 15(4):1649-54. PubMed ID: 24641383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients.
    Zheng YW; Wang KP; Zhou JJ; Zhang ZQ; Xiong L; Wen Y; Zou H
    Scand J Gastroenterol; 2018 Dec; 53(12):1562-1568. PubMed ID: 30572742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study.
    Pei Y; Chai S; Zhang Y; Zhang Z; Chen X; Zhang W
    J Gastrointest Surg; 2019 Nov; 23(11):2151-2162. PubMed ID: 30511133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values.
    Hidaka M; Eguchi S; Hara T; Soyama A; Okada S; Hamada T; Ono S; Adachi T; Kanetaka K; Takatsuki M
    J Invest Surg; 2020 Feb; 33(2):118-122. PubMed ID: 29856668
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
    He W; Zeng Q; Zheng Y; Chen M; Shen J; Qiu J; Chen M; Zou R; Liao Y; Li Q; Wu X; Li B; Yuan Y
    BMC Cancer; 2015 Apr; 15():263. PubMed ID: 25886495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.
    Citterio D; Facciorusso A; Sposito C; Rota R; Bhoori S; Mazzaferro V
    JAMA Surg; 2016 Sep; 151(9):846-53. PubMed ID: 27248425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
    Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
    Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma.
    Wang YY; Xiang BD; Ma L; Zhong JH; Ye JZ; Wang K; Xing BC; Li LQ
    Ann Surg; 2021 Dec; 274(6):e1209-e1217. PubMed ID: 32097166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.